TERN
Terns Pharmaceuticals, Inc.
$52.95
+0.00 (+0.00%)
At close · May 7
Market Cap
$6.12B
Shares
115,521,157
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-05 | — | |
| 10-K/A | 2026-04-27 | 2025-12-31 | |
| 8-K | 2026-04-27 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-03-25 | 2026-03-24 | |
| 8-K | 2026-01-22 | 2026-01-16 | |
| 8-K | 2026-01-09 | 2026-01-07 | |
| 8-K | 2025-12-11 | 2025-12-09 | |
| 8-K | 2025-12-08 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-22 | 2025-10-21 | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-06-16 | 2025-06-11 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-29 | 2025-06-11 | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-02-24 | 2025-02-22 | |
| 8-K | 2025-02-20 | — | |
| 8-K | 2025-02-06 | 2025-02-01 | |
| 8-K | 2024-12-03 | — | |
| 8-K | 2024-11-18 | 2024-11-14 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-09-12 | 2024-09-10 | |
| 8-K | 2024-09-09 | — | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| 8-K | 2024-08-05 | — | |
| 8-K | 2024-07-29 | 2024-07-23 | |
| 8-K | 2024-07-03 | 2024-07-01 | |
| 8-K | 2024-06-12 | 2024-06-10 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 8-K | 2024-04-29 | — | |
| DEF 14A | 2024-04-25 | 2024-06-10 | |
| 8-K | 2024-03-14 | — | |
| 10-K | 2024-03-14 | 2023-12-31 | |
| 8-K | 2024-02-07 | 2024-02-06 | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-10-10 | 2023-10-04 | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-08-03 | — | |
| 8-K | 2023-06-14 | 2023-06-12 |
Showing 1–50 of 88 filings